[1]
S. M. Jungić, B. Tubić, R. Gajanin, Z. Gojković, i I. Rakita, „Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer“, Vojnosanit Pregl, vol 74, izd. 3, str. 249–255, Juni 2017, doi: 10.2298/VSP150513173J.